Status:
RECRUITING
Retrospective Study on Microbial Diversity in Paraffin Tissue of Pancreatic Diseases
Lead Sponsor:
Ruijin Hospital
Conditions:
Pancreatic Cancer
Pancreatic Disease
Eligibility:
All Genders
5-85 years
Brief Summary
The great harm of pancreatic diseases and the unknown etiology and pathogenesis make it difficult to intervene in most early cases in time. Previous studies by scholars and applicants at home and abro...
Detailed Description
AIMS: To explore the correlation between the characteristics of microbial flora in pancreas and clinical and pathological characteristics of patients with various pancreatic diseases; To clarify the ...
Eligibility Criteria
Inclusion
- Age ≥ 5 years old, ≤ 85 years old;
- After MDT discussion, routine surgery can be performed, and the postoperative pathology is clear as pancreatic cancer and other pancreatic diseases;
- No history of antibiotics for three months before surgery, no history of yogurt containing probiotics
- There is no serious damage to heart, liver and kidney function.
Exclusion
- Antibiotics or yogurt containing probiotics history in three months;
- Patients with evidence of sensory or motor neuropathy;
- Those who have a clear cardiovascular disease, severe associated disease or active infection, including known HIV infection;
- Those who have a history of other cancers.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT05193162
Start Date
February 1 2019
End Date
July 31 2026
Last Update
June 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ruijin Hospital
Shanghai, China, 200025